GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Advanced BioMedical Technologies Inc (OTCPK:ABMT) » Definitions » Quick Ratio

Advanced BioMedical Technologies (Advanced BioMedical Technologies) Quick Ratio : 0.01 (As of Jul. 2021)


View and export this data going back to 2007. Start your Free Trial

What is Advanced BioMedical Technologies Quick Ratio?

The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. It is calculated as a company's Total Current Assets excludes Total Inventories divides by its Total Current Liabilities. Advanced BioMedical Technologies's quick ratio for the quarter that ended in Jul. 2021 was 0.01.

Advanced BioMedical Technologies has a quick ratio of 0.01. It indicates that the company cannot currently fully pay back its current liabilities.

The historical rank and industry rank for Advanced BioMedical Technologies's Quick Ratio or its related term are showing as below:

ABMT's Quick Ratio is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 2.055
* Ranked among companies with meaningful Quick Ratio only.

Advanced BioMedical Technologies Quick Ratio Historical Data

The historical data trend for Advanced BioMedical Technologies's Quick Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Advanced BioMedical Technologies Quick Ratio Chart

Advanced BioMedical Technologies Annual Data
Trend Oct11 Oct12 Oct13 Oct14 Oct15 Oct16 Oct17 Oct18 Oct19 Oct20
Quick Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.01 - 0.01 0.01 0.03

Advanced BioMedical Technologies Quarterly Data
Oct16 Jan17 Apr17 Jul17 Oct17 Jan18 Apr18 Jul18 Oct18 Jan19 Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21
Quick Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.01 0.03 0.01 0.01 0.01

Competitive Comparison of Advanced BioMedical Technologies's Quick Ratio

For the Medical Devices subindustry, Advanced BioMedical Technologies's Quick Ratio, along with its competitors' market caps and Quick Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Advanced BioMedical Technologies's Quick Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Advanced BioMedical Technologies's Quick Ratio distribution charts can be found below:

* The bar in red indicates where Advanced BioMedical Technologies's Quick Ratio falls into.



Advanced BioMedical Technologies Quick Ratio Calculation

The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. For this reason, the ratio excludes inventories from current assets.

Advanced BioMedical Technologies's Quick Ratio for the fiscal year that ended in Oct. 2020 is calculated as

Quick Ratio (A: Oct. 2020 )=(Total Current Assets-Total Inventories)/Total Current Liabilities
=(0.331-0.1)/7.864
=0.03

Advanced BioMedical Technologies's Quick Ratio for the quarter that ended in Jul. 2021 is calculated as

Quick Ratio (Q: Jul. 2021 )=(Total Current Assets-Total Inventories)/Total Current Liabilities
=(0.243-0.189)/8.579
=0.01

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Advanced BioMedical Technologies  (OTCPK:ABMT) Quick Ratio Explanation

The quick ratio is more conservative than the Current Ratio because it excludes inventories from current assets. The ratio derives its name presumably from the fact that assets such as cash and marketable securities are quick sources of cash. Inventories generally take time to be converted into cash, and if they have to be sold quickly, the company may have to accept a lower price than book value of these inventories. As a result, they are justifiably excluded from assets that are ready sources of immediate cash.

In general, low or decreasing quick ratios generally suggest that a company is over-leveraged, struggling to maintain or grow sales, paying bills too quickly or collecting receivables too slowly. On the other hand, a high or increasing quick ratio generally indicates that a company is experiencing solid top-line growth, quickly converting receivables into cash, and easily able to cover its financial obligations. Such companies often have faster inventory turnover and cash conversion cycles.

The higher the quick ratio, the better the company's liquidity position.


Advanced BioMedical Technologies Quick Ratio Related Terms

Thank you for viewing the detailed overview of Advanced BioMedical Technologies's Quick Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Advanced BioMedical Technologies (Advanced BioMedical Technologies) Business Description

Traded in Other Exchanges
N/A
Address
200 Park Avenue, Suite 1700, New York, NY, USA, 10166
Advanced BioMedical Technologies Inc is engaged in designing, developing, manufacturing, and the planned future marketing of self-reinforced, re-absorbable biodegradable internal fixation devices. The company manufactures its products using Polyamide, and it is used in a variety of applications, which include orthopaedic trauma, sports-related medical treatment, cartilage injuries, and reconstructive dental procedures. Its Polyamide products include screws, rods, and binding wires consisting of enhanced fibres and high molecular polymers, which are designed to facilitate quick healing of complex fractures in many areas of the human skeletal system.
Executives
Advanced Biomedical Technologies Inc. director, officer: CFO 200 PARK AVENUE, SUITE 1700 NEW YORK NY 10166
Lynch John Thomas Jr other: Advisor 22 MULBERRY STREET SUITE 1B MIDDLETOWN NY 10940
Chi Ming Yu director, 10 percent owner, officer: PRESIDENT 36 CLAREMONT TERRACE WAYNE NJ 07470
Andriy Protskiv director, 10 percent owner, officer: President, CEO, CFO 706-15038 101 AVENUE SURREY A1 V3R 0N2

Advanced BioMedical Technologies (Advanced BioMedical Technologies) Headlines